ReviewCurrent heart failure reports2025
Cardiogenic Shock; Health Disparities; Equity; Mechanical Circulatory Support; Sex Differences; Multidisciplinary Care; Protocolized Care.
Review in Current heart failure reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewThis review examines why substantial disparities persist in the management of cardiogenic shock (CS) despite advances in therapy and the existence of clinical guidelines. We synthesize structural, clinical, and ethical mechanisms that shape access to timely and advanced care and highlight equity-oriented solutions. RECENT
findingsAcross contemporary cohorts, women, older adults, racial/ethnic minorities, and socioeconomically disadvantaged patients remain less likely to receive early coronary angiography, revascularization, or mechanical circulatory support (MCS) and experience longer inter-hospital transfer delays. Reported gaps typically range from ~ 20-40% lower use of guideline-recommended therapies compared with reference groups, independent of comorbidity and presentation severity. Drivers include implicit bias, variable institutional resources, uneven protocol activation, and discretionary triage under time pressure. Equity in CS care cannot be achieved by protocols alone. It requires deliberate measurement, culturally responsive decision-making, and system-level accountability. Equity-minded implementation of protocolized care, regionalized hub-and-spoke networks, multidisciplinary shock teams, and disparity-sensitive metrics shows promise. Success in CS should be defined not only as survival but also as equitable inclusion in the full spectrum of recognition, triage, escalation, and shared decision-making.
Indexed as
Identifiers
41258337What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.